title: Incorporating imaging into personalized medicine for the detection of prostate cancer: Pharmacological research-Urogenital pharmacology.
abstract: Imaging has played an important role in the administration of personalized medicine. From diagnosing diseases to guiding therapies, imaging has become an all-encompassing modality. With respect to prostate cancer, personalized management of the disease has been transformed by imaging. Specifically, multiparametric magnetic resonance imaging has emerged as a vital player in the detection, characterization, and localization of the disease thus making the incorporation of imaging in personalized prostate cancer management integral. In this review, the current role of imaging in personalized medicine for the management of prostate cancer is discussed.
authors: Molecular Imaging Program, NCI, NIH, Bethesda, MD, USA.
authors: Francesca
authors: F
authors: Mertan
authors: Molecular Imaging Program, NCI, NIH, Bethesda, MD, USA. Electronic address: turkbeyi@mail.nih.gov.
authors: Baris
authors: B
authors: Turkbey
mesh_terms: D000818:Animals; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods; D057285:Precision Medicine / Q000379:methods*; D011467:Prostate / Q000000981:diagnostic imaging* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy
keywords: Imaging; MRI; Personalized medicine; Prostate; Prostate cancer; mpMRI